DTC advertising, what it does and doesn't allow
The rules that apply specifically to promotion aimed at patients rather than prescribers.
Direct-to-consumer advertising, promotional content aimed at patients and the general public rather than prescribers, is legal for prescription drugs in relatively few countries, and even where it is legal, it carries a distinct set of rules from content aimed at healthcare professionals.
What it is
DTC covers broadcast ads, digital display, and patient-facing web content, anything promoting a prescription drug directly to the people who might ask their doctor for it, rather than to the clinicians who prescribe it. This is a meaningfully different audience from HCP-facing formats like detailing materials or journal ads, and the rules reflect that difference: DTC content is judged against what an average patient, without clinical training, would understand from it, not what a trained prescriber would understand.
Why it matters
DTC advertising carries its own layer of requirements on top of the general rules that apply to all promotion. The most well known is the broadcast major statement requirement: broadcast DTC ads (television and radio) have to either present the drug's most important risk information within the ad itself, in a way an average viewer can absorb, or direct the audience clearly to where that information is available (a website, a toll-free number, a print ad running alongside it).
This exists because broadcast is a format where a viewer typically can't pause, rewind, or look something up mid-ad, which is a different comprehension bar than print or a webpage a patient can read at their own pace.
How it actually works
A few things that specifically distinguish DTC from HCP-facing promotion:
- Audience-appropriate language: claims and risk information need to be understandable to a general audience, not written at a clinical reading level, which affects word choice as much as it affects content.
- The broadcast major statement: for TV and radio specifically, the drug's most significant risks need to be communicated clearly within the format's real-time constraints, or the ad needs to point clearly to where that information lives.
- Reminder ads and help-seeking ads: some formats mention a drug by name without stating an indication (a reminder ad), or discuss a condition without naming a specific drug (a help-seeking ad). Each carries a different set of requirements than a full product ad that both names the drug and states what it treats.
Common misunderstandings
A common misread is assuming DTC rules are simply a lighter version of HCP-facing rules, since the audience isn't clinically trained. In several respects the opposite is true: because the audience lacks clinical background, DTC content is held to a stricter comprehension standard for risk information, not a looser one. The bar isn't "a clinician could understand this," it's "an average patient, hearing this once, would actually absorb it."